The National Radium-223 Dichloride Audit group: Data from patients in UK oncology centers with metastatic castration-resistant prostate cancer treated with radium-223 dichloride.

被引：0
|
作者：
Randhawa, Manreet
Jones, Robert J.
Stratton, Irene
机构：
[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[3] Gloucestershire Retinal Res Grp, Cheltenham, Glos, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer
    Borso, Elisa
    Boni, Giuseppe
    Galli, Luca
    Ricci, Sergio
    Farnesi, Azzurra
    Mazzarri, Sara
    Cianci, Claudia
    Mariani, Giuliano
    Falcone, Alfredo
    [J]. FUTURE ONCOLOGY, 2015, 11 (02) : 323 - 331
  • [42] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [43] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Yong Du
    Ignasi Carrio
    Giuseppe De Vincentis
    Stefano Fanti
    Harun Ilhan
    Caroline Mommsen
    Egbert Nitzsche
    Francis Sundram
    Wouter Vogel
    Wim Oyen
    Val Lewington
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1671 - 1678
  • [44] Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
    Aprile, Carlo
    Persico, Marco G.
    Lodola, Lorenzo
    Buroni, Federica E.
    [J]. WORLD JOURNAL OF RADIOLOGY, 2016, 8 (10): : 816 - 818
  • [45] Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer
    Anido-Herranz, Urbano
    Fernandez-Calvo, Ovidio
    Ruiz-Banobre, Juan
    Martinez-Breijo, Sara
    Fernandez-Nunez, Natalia
    Nogareda-Seoane, Zulema
    Garrido-Pumar, Miguel
    Casas-Nebra, Javier
    Muniz-Garcia, Gloria
    Portela-Pereira, Paula
    Gomez-Caamano, Antonio
    Perez-Fentes, Daniel Adolfo
    Santome-Couto, Lucia
    Lazaro, Martin
    Molina-Diaz, Aurea
    Medina-Colmenero, Ana
    Vazquez-Estevez, Sergio
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
  • [47] UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY
    Lapierre, M.
    Fraelic, A.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A162 - A162
  • [48] Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity
    Gomez-Veiga, F.
    Alvarez-Ossorio, J. L.
    Carballido-Rodriguez, J.
    Juarez-Soto, A.
    Rodriguez-Antolin, A.
    Cozar-Olmo, J. M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (10): : 616 - 624
  • [49] Radium-223 dichloride: a new paradigm in the treatment of prostate cancer
    Anido Herranz, Urbano
    Fernandez Calvo, Ovidio
    Afonso Afonso, Francisco Javier
    Martinez de Llano, Sofia Rodriguez
    Lazaro Quintela, Martin
    Leon Mateos, Luis
    Vazquez Estevez, Sergio
    Anton Aparicio, Luis Miguel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 339 - 348
  • [50] Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)
    Hijab, A.
    Tunariu, N.
    Tovey, H.
    Alonzi, R.
    Tree, A.
    Staffurth, J.
    Blackledge, M.
    Padhani, A. R.
    Stidwill, H.
    Finch, J.
    Chatfield, P.
    Perry, S.
    Koh, D-M.
    Hall, E.
    Parker, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S539 - S539
12345